In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clotrimaderm Drug Master File in Korea (Clotrimaderm KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clotrimaderm. The MFDS reviews the Clotrimaderm KDMF as part of the drug registration process and uses the information provided in the Clotrimaderm KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clotrimaderm KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clotrimaderm API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clotrimaderm suppliers with KDMF on PharmaCompass.